Boehringer Ingelheim denied preliminary injunction against Zentiva by UPC
Boehringer Ingelheim International has seen the Unified Patent Court reject a request for provisional measures against Zentiva related to its generic nintedanib medicines used to treat lung fibrosis and cancer. The...To view the full article, register now.
Already a subscriber? Click here to view full article